Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Immuno Oncology Assays Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Immunoassay
  • 1.4.3 Flow Cytometry
  • 1.4.4 PCR
  • 1.4.5 Next Generation Sequencing
• 1.5 Market by Application
  • 1.5.1 Global Immuno Oncology Assays Market Share by Application (2014-2025)
  • 1.5.2 Research
  • 1.5.3 Clinical Diagnostics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Immuno Oncology Assays Market Size
• 2.2 Immuno Oncology Assays Growth Trends by Regions
  • 2.2.1 Immuno Oncology Assays Market Size by Regions (2014-2025)
  • 2.2.2 Immuno Oncology Assays Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Immuno Oncology Assays Market Size by Manufacturers
  • 3.1.1 Global Immuno Oncology Assays Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Immuno Oncology Assays Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Immuno Oncology Assays Market Concentration Ratio (CR5 and HHI)
• 3.2 Immuno Oncology Assays Key Players Head office and Area Served
• 3.3 Key Players Immuno Oncology Assays Product/Solution/Service
• 3.4 Date of Enter into Immuno Oncology Assays Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Immuno Oncology Assays Market Size by Type (2014-2019)
• 4.2 Global Immuno Oncology Assays Market Size by Application (2014-2019)

5 United States

• 5.1 United States Immuno Oncology Assays Market Size (2014-2019)
• 5.2 Immuno Oncology Assays Key Players in United States
• 5.3 United States Immuno Oncology Assays Market Size by Type
• 5.4 United States Immuno Oncology Assays Market Size by Application

6 Europe

• 6.1 Europe Immuno Oncology Assays Market Size (2014-2019)
• 6.2 Immuno Oncology Assays Key Players in Europe
• 6.3 Europe Immuno Oncology Assays Market Size by Type
• 6.4 Europe Immuno Oncology Assays Market Size by Application

7 China

• 7.1 China Immuno Oncology Assays Market Size (2014-2019)
• 7.2 Immuno Oncology Assays Key Players in China
• 7.3 China Immuno Oncology Assays Market Size by Type
• 7.4 China Immuno Oncology Assays Market Size by Application

8 Japan

• 8.1 Japan Immuno Oncology Assays Market Size (2014-2019)
• 8.2 Immuno Oncology Assays Key Players in Japan
• 8.3 Japan Immuno Oncology Assays Market Size by Type
• 8.4 Japan Immuno Oncology Assays Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Immuno Oncology Assays Market Size (2014-2019)
• 9.2 Immuno Oncology Assays Key Players in Southeast Asia
• 9.3 Southeast Asia Immuno Oncology Assays Market Size by Type
• 9.4 Southeast Asia Immuno Oncology Assays Market Size by Application

10 India

• 10.1 India Immuno Oncology Assays Market Size (2014-2019)
• 10.2 Immuno Oncology Assays Key Players in India
• 10.3 India Immuno Oncology Assays Market Size by Type
• 10.4 India Immuno Oncology Assays Market Size by Application

11 Central & South America

• 11.1 Central & South America Immuno Oncology Assays Market Size (2014-2019)
• 11.2 Immuno Oncology Assays Key Players in Central & South America
• 11.3 Central & South America Immuno Oncology Assays Market Size by Type
• 11.4 Central & South America Immuno Oncology Assays Market Size by Application

12 International Players Profiles

• 12.1 Thermo Fischer Scientific
  • 12.1.1 Thermo Fischer Scientific Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Immuno Oncology Assays Introduction
  • 12.1.4 Thermo Fischer Scientific Revenue in Immuno Oncology Assays Business (2014-2019)
  • 12.1.5 Thermo Fischer Scientific Recent Development
• 12.2 Roche Diagnostics
  • 12.2.1 Roche Diagnostics Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Immuno Oncology Assays Introduction
  • 12.2.4 Roche Diagnostics Revenue in Immuno Oncology Assays Business (2014-2019)
  • 12.2.5 Roche Diagnostics Recent Development
• 12.3 Agilent Technologies
  • 12.3.1 Agilent Technologies Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Immuno Oncology Assays Introduction
  • 12.3.4 Agilent Technologies Revenue in Immuno Oncology Assays Business (2014-2019)
  • 12.3.5 Agilent Technologies Recent Development
• 12.4 Illumina
  • 12.4.1 Illumina Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Immuno Oncology Assays Introduction
  • 12.4.4 Illumina Revenue in Immuno Oncology Assays Business (2014-2019)
  • 12.4.5 Illumina Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoint receptors, bi-specific antibodies, small molecules, or cellular therapies such as chimeric antigen receptor T-cells (CAR-T).
In 2018, the global Immuno Oncology Assays market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Immuno Oncology Assays status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immuno Oncology Assays development in United States, Europe and China.

The key players covered in this study
Thermo Fischer Scientific
Roche Diagnostics
Agilent Technologies
Illumina
...

Market segment by Type, the product can be split into
Immunoassay
Flow Cytometry
PCR
Next Generation Sequencing

Market segment by Application, split into
Research
Clinical Diagnostics

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Immuno Oncology Assays status, future forecast, growth opportunity, key market and key players.
To present the Immuno Oncology Assays development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Immuno Oncology Assays are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.